ChLIA Fully Automated Platform Unveiled by Revvity’s EUROIMMUN
Revvity, Inc. has launched the IDS i20, a fully automated, high-throughput platform for ChLIA, enabling labs to consolidate specialty tests.
Tag: EuroImmun
All
Latest
All
Latest
Supplemental March/April 2023 Tech Guide: LIS & Operational Middleware
The Supplemental March/April 2023 Tech Guide features a wide-range of products that were not featured in the March/April print issue.
All
Latest
Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected Covid-19 Patients
EuroImmun’s CE-marked Antigen ELISA is able to be applied in semi quantitative automatable detection of the SARS-CoV-2 nucleocapsid protein on a large scale.
First Commercial Serological Tests Available for Zika Virus Detection
The new tests are designed to overcome problems of flavivirus crossreactivity.
Read More
Inside Track: First Mover
With scientific intensity, EuroImmun has launched the first specific serological test for Zika virus.
Read More